Russell Blackford

50 Voices of Disbelief

Why We Are Atheists

Buch

50 Voices of Disbelief: Why We Are Atheists presents a unique and thought-provoking collection of original essays that address personal disbelief in a higher power . Drawn from an international cast of professionals in the fields of academia, science, literature, media and politics, contributors offer carefully considered statements of why they reject the idea of a deity governing the universe and human affairs. Several essays also address such issues as the social role of religion and its alternatives. The responses feature a stunning diversity of viewpoints and tone, ranging from rigorous philosophical arguments to highly personal -- at tim… Mehr

CHF 131.00

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen

V112: Lieferbar in ca. 10-20 Arbeitstagen

Produktdetails

Weitere Autoren: Schüklenk, Udo

ISBN: 978-1-4051-9045-9
EAN: 9781405190459
Produktnummer: 6413868
Verlag: Wiley
Sprache: Englisch
Erscheinungsjahr: 2009
Seitenangabe: 360 S.
Masse: H23.9 cm x B16.3 cm x D2.5 cm 626 g
Gewicht: 626

Über den Autor

Russell Blackford is a freelance writer, critic, and editor, based in Melbourne, Australia. He teaches part-time in the School of Philosophy and Bioethics at Monash University, where he specialises mainly in philosophical bioethics and legal/political philosophy. He is Editor-in-Chief of the Journal of Evolution and Technology, an on-line peer reviewed journal devoted to rigorous consideration of future prospects for the human species or its possible descendants.Udo Schüklenk is a German-Australian philosopher. He has written or edited five books and published over one hundred articles in peer reviewed journals and books. His latest books are the co-edited volumes The Power of Pills (2006) and The Bioethics Reader (Blackwell, 2007). He is the Joint Editor-in-Chief of the international journal Bioethics and currently the Ontario Research Chair in Bioethics at Queen's University in Canada. His current research focuses on ethical and policy issues in drug research and development.